Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Franco Scaldaferri
Observed name:
Scaldaferri, Franco
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-8334-7541
Observed ORCID:
0000-0001-8334-7541
OpenAlex ID:
A5135215193
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-Line Therapy in Anti-Tumor Necrosis Factor-Experienced Patients With Ulcerative Colitis
2026
·
Giuseppe Privitera
, Cristina Bezzio
, et al.
·
Clinical Gastroenterology and Hepatology
·
7
Determinants of Telemedicine Satisfaction in Inflammatory Bowel Disease Patients: A Multi-Centre Cross-Sectional Study
2026
·
Piergiorgio Martella
, Alessio Lo Cascio
, et al.
·
Medicina
·
2
PDF
Capsule endoscopy for treat-to-target monitoring in Crohn’s disease: a systematic review and meta-analysis
2026
·
Clelia Marmo
, Francesca Sofia Puca
, et al.
·
Gastrointestinal Endoscopy
·
1
Perceived Satisfaction of Outpatients Undergoing Endoscopic Examination: A Cross-Sectional Observational Study
2026
·
Fabio Grilli
, Alessio Lo Cascio
, et al.
·
Digestive Diseases
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE Study
2026
·
Adis journals on behalf of
, Giuseppe Privitera
, et al.
·
Figshare
The Economic Burden of Disease-Related Malnutrition in Inflammatory Bowel Disease: A Nationwide Study from Italy
2026
·
Scortichini, Matteo
, Caprioli, Flavio
, et al.
·
Nutrimentum et Curae
1119 Capsule Endoscopy for Treat-to-target Monitoring in Crohn's Disease: a Systematic Review and Meta-analysis
2026
·
Clelia Marmo
, Francesca Sofia Puca
, et al.
·
Gastrointestinal Endoscopy
724 Impact of Obefazimod Treatment on Histologic and Combined Histologic-endoscopic Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Abtect-1 and Abtect-2 Phase 3, Double-blind, Placebo-controlled Induction Trials
2026
·
Fernando Magro
, Bruce E. Sands
, et al.
·
Gastrointestinal Endoscopy
Mo1461 MEDITERRANEAN DIET ENHANCES ALPHA DIVERSITY AND DISEASE ACTIVITY, WHILE FMT REDUCES DISEASE ACTIVITY IN A DONORDEPENDENT MANNER
2026
·
Sara Deleu
, Sara Troisi
, et al.
·
Gastroenterology
Su1630 UPADACITINIB: PERSONALIZED GOALS FOR REMISSION AND DISEASE EVALUATION IN PATIENTS WITH CROHN’S DISEASE (UPGRADE-CD) - A MULTICENTER PROSPECTIVE STUDY FROM THE ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASES (IG-IBD)
2026
·
Brigida Barberio
, Franco Scaldaferri
, et al.
·
Gastroenterology
Mo1461 MEDITERRANEAN DIET ENHANCES ALPHA DIVERSITY AND DISEASE ACTIVITY, WHILE FMT REDUCES DISEASE ACTIVITY IN A DONORDEPENDENT MANNER
2026
·
Sara Deleu
, Sara Troisi
, et al.
·
Gastrointestinal Endoscopy
724 Impact of Obefazimod Treatment on Histologic and Combined Histologic-endoscopic Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Abtect-1 and Abtect-2 Phase 3, Double-blind, Placebo-controlled Induction Trials
2026
·
Fernando Magro
, Bruce E. Sands
, et al.
·
Gastroenterology
1119 Capsule Endoscopy for Treat-to-target Monitoring in Crohn's Disease: a Systematic Review and Meta-analysis
2026
·
Clelia Marmo
, Francesca Sofia Puca
, et al.
·
Gastroenterology
Sa1621 LONG-TERM OUTCOME OF PATIENTS WITH ULCERATIVE COLITIS AFTER ILEAL POUCH–ANAL ANASTOMOSIS: THE LATIUM NET STUDY, PRELIMINARY DATA
2026
·
Giuseppe Cuccia
, Annalisa Aratari
, et al.
·
Gastroenterology
Sa1621 LONG-TERM OUTCOME OF PATIENTS WITH ULCERATIVE COLITIS AFTER ILEAL POUCH–ANAL ANASTOMOSIS: THE LATIUM NET STUDY, PRELIMINARY DATA
2026
·
Giuseppe Cuccia
, Annalisa Aratari
, et al.
·
Gastrointestinal Endoscopy
Show more works
View as search
Works count:
15
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type